Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · IEX Real-Time Price · USD
194.38
-10.27 (-5.02%)
At close: Apr 25, 2024, 4:00 PM
199.69
+5.31 (2.73%)
After-hours: Apr 25, 2024, 7:50 PM EDT
Madrigal Pharmaceuticals Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for MDGL stock have an average target of 355.36, with a low estimate of 150 and a high estimate of 425. The average target predicts an increase of 82.82% from the current stock price of 194.38.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MDGL stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 2 | 2 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 1 | 1 | 1 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 1 | 0 | 0 |
| Total | 9 | 9 | 7 | 7 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Sell Initiates $150 | Sell | Initiates | $150 | -22.83% | Apr 22, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $325 → $405 | Buy | Maintains | $325 → $405 | +108.35% | Mar 20, 2024 |
| UBS | UBS | Strong Buy Maintains $337 → $410 | Strong Buy | Maintains | $337 → $410 | +110.93% | Mar 15, 2024 |
| TD Cowen | TD Cowen | Buy Maintains $349 → $390 | Buy | Maintains | $349 → $390 | +100.64% | Mar 15, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Sell → Hold Upgrades $155 → $270 | Strong Sell → Hold | Upgrades | $155 → $270 | +38.90% | Mar 15, 2024 |
Financial Forecast
Revenue This Year
90.83M
Revenue Next Year
387.26M
from 90.83M
Increased by 326.34%
EPS This Year
-23.95
from -19.99
EPS Next Year
-14.75
from -23.95
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 118.0M | 534.7M | 1.5B | 3.2B | 5.4B |
| Avg | 90.8M | 387.3M | 950.0M | 1.9B | 2.7B |
| Low | 59.9M | 197.7M | 214.0M | 773.8M | 1.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 488.6% | 280.4% | 239.3% | 179.1% |
| Avg | - | 326.3% | 145.3% | 102.7% | 37.9% |
| Low | - | 117.7% | -44.8% | -18.5% | -43.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -14.35 | -3.21 | 28.77 | 121.40 | 217.34 |
| Avg | -23.95 | -14.75 | 6.70 | 55.55 | 84.44 |
| Low | -31.57 | -26.73 | -16.04 | 25.70 | 32.62 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 1,712.6% | 291.3% |
| Avg | - | - | - | 729.4% | 52.0% |
| Low | - | - | - | 283.6% | -41.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.